CG200745 PPA

DRUG2 trials

Sponsors

CrystalGenomics, Inc.

Conditions

Myelodysplastic SyndromePancreatic Neoplasms

Phase 1

Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

CrystalGenomics, Inc.Pancreatic Neoplasms

Start: 2016-03-31End: 2019-08-31Target: 24Updated: 2019-06-17

Phase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome

CrystalGenomics, Inc.Myelodysplastic Syndrome

Start: 2016-06-30End: 2023-12-31Target: 36Updated: 2023-09-13